Summary

Scott Schliebner, Senior Vice President, Center for Rare Diseases at PRA Health Sciences talks about how amore patient-centred approach is needed to increase par ticipation and access, and how technology may hold the key.

Register to download

The Future of Clinical Trials: Connected and Virtual Approaches for Rare Diseases

You may also be interested in: